DOCSLIB.ORG

Front Matter

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Front Matter ANTICANCER RESEARCH International Journal of Cancer Research and Treatment ISSN: 0250-7005 Volume 40, Number 1, January 2020 Contents Review Current Treatment of Colorectal Liver Metastasis as a Chronic Disease. N.M. DÖRR, M. BARTELS, M.H. MORGUL (Leipzig; Münster, Germany) ......................................................................................................................... 1 Experimental Studies SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly Through the Modulation of cIAP2. K.L. STEED, H.R. JORDAN, T.O. TOLLEFSBOL (Birmingham, AL, USA) .......................................... 9 Genetic Polymorphisms in IL-10 Promoter Are Associated With Smoking and Prostate Cancer Risk in African Americans. M. ABBAS, T. MASON, A. IBAD, M. KHRAIWESH, V. APPREY, Y. KANAAN, B. WILSON, G. DUNSTON, L. RICKS-SANTI, H. BRIM (Washington, DC; Silver Spring, MD; Hampton, VA, USA) ................. 27 High Expression of c-Met, PKC λ and ALDH1A3 Predicts a Poor Prognosis in Late-stage Breast Cancer. H. MOTOMURA, Y. NOZAKI, C. ONAGA, A. OZAKI, S. TAMORI, T.-A. SHIINA, S. KANAI, C. OHIRA, Y. HARA, Y. HARADA, R. TAKASAWA, T. HANAWA, S.-I. TANUMA, Y. MANO, T. SATO, K. SATO, K. AKIMOTO (Chiba, Japan) ............................................................................................................................................... 35 Targeting Fibroblast Growth Factor Receptor (FGFR) and Phosphoinositide 3-kinase (PI3K) Signaling Pathways in Medulloblastoma Cell Lines. S. HOLZHAUSER, M. LUKOSEVICIUTE, T. ANDONOVA, R.G. URSU, T. DALIANIS, M. WICKSTRÖM, O.N. KOSTOPOULOU (Stockholm, Sweden; Iasi, Romania) ............................. 53 Cisplatin Induced the Expression of SEI1 (TRIP-Br1) Oncogene in Human Oral Squamous Cancer Cell Lines. J. LI, Z. VANGUNDY, M. POI (Columbus, OH, USA) ................................................................................................. 67 Contents continued on the back cover ISSN (print): 0250-7005 ISSN (online): 1791-7530 Editorial Board Editorial Office: International Institute of Anticancer Research, 1st km Kapandritiou-Kalamou Rd., Kapandriti, P.O. Box 22, Attiki 19014, P. A. ABRAHAMSSON , Malm , Sweden S. D. KOTTARIDIS, Athens, Greece ö Greece. Tel / Fax: +30-22950-53389. B. B. AGGARWAL, San Diego, CA, USA G. R. F. KRUEGER, K ln, Germany ö U.S. Branch: Anticancer Research USA, Inc., 111 Bay Avenue, T. AKIMOTO, Kashiwa, Chiba, Japan Pat M. KUMAR, Manchester, UK Highlands, NJ 07732, USA. P. Z. ANASTASIADIS, Jacksonville, FL, USA Shant KUMAR, Manchester, UK E-mails: Editorial Office: [email protected] A. ARGIRIS, San Antonio, TX, USA O. D. LAERUM, Bergen, Norway Managing Editor: [email protected] J. P. ARMAND, Toulouse, France F. J. LEJEUNE, Lausanne, Switzerland ANTICANCER RESEARCH supports: (a) the establishment and the V. I. AVRAMIS, Los Angeles, CA, USA S. LINDER, Link ping, Sweden ö activities of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH D.-T. BAU, Taichung, Taiwan, ROC L. F. LIU, Piscataway, NJ, USA (IIAR; Kapandriti, Attiki, Greece); and (b) the organization of the G. BAUER, Freiburg, Germany D. M. LOPEZ, Miami, FL, USA International Conferences of Anticancer Research. The IIAR is a member of UICC. For more information about ANTICANCER RESEARCH, IIAR and E. E. BAULIEU, Le Kremlin-Bicetre, France E. LUNDGREN, Um ea°, Sweden E. J. BENZ , Jr., Boston, MA, USA Y. MAEHARA, Fukuoka, Japan the Conferences, please visit the IIAR website: www.iiar-anticancer.org J. BERGH, Stockholm, Sweden J. MAHER , London, UK Publication Data: ANTICANCER RESEARCH (AR) is published F. T. BOSMAN, Lausanne, Switzerland J. MARESCAUX, Strasbourg, France bimonthly from January 1981 to December 2008 and monthly from January 2009. Each annual volume comprises 12 issues. Annual Author M. BOUVET, La Jolla, CA, USA J. MARK, Sk vde, Sweden ö and Subject Indices are included in the last issue of each volume. S. S. MARTIN, Baltimore, MD, USA J. BOYD, Miami, FL, USA ANTICANCER RESEARCH Vol. 24 (2004) and onwards appears online G. BROICH, Monza, Italy S. MITRA, Houston, TX, USA with Stanford University HighWire Press from April 2009. S. BRULAND, Oslo, Norway S. MIYAMOTO, Fukuoka, Japan Ø Copyright: On publication of a manuscript in AR, which is a J. M. BUATTI, Iowa City, IA, USA S. MONCADA, Manchester, UK copyrighted publication, the legal ownership of all published parts of M. M. BURGER, Basel, Switzerland M. MUELLER, Villingen-Schwenningen, the paper passes from the Author(s) to the Journal. M. CARBONE, Honolulu, HI, USA Germany Annual Subscription Rates 2020 per volume: Institutional subscription C. CARLBERG, Kuopio, Finland F. M. MUGGIA, New York, NY, USA US$ 1,898.00 (online) or US$ 2,277.00 (print & online). Personal J. CARLSSON, Uppsala, Sweden M. NAMIKI, Kanazawa, Ishikawa, Japan subscription US$ 897.00 (online) or US$ 1,277.00 (print & online). A. F. CHAMBERS, London, ON, Canada R. NARAYANAN, Boca Raton, FL, USA Prices include rapid delivery and insurance. The complete previous P. CHANDRA, Frankfurt am Main, Germany K. NILSSON, Uppsala, Sweden volumes of Anticancer Research (Vol. 1-39, 1981-2019) are available at L. CHENG, Indianapolis, IN, USA S. PATHAK, Houston, TX, USA 50% discount on the above rates. J.-G. CHUNG , Taichung, Taiwan, ROC J.L. PERSSON, Malm , Sweden Subscription Orders: Orders can be placed at agencies, bookstores, or ö directly with the Publisher. (e-mail: [email protected]) R. CLARKE, Washington, DC, USA G. J. PILKINGTON, Portsmouth, UK E. DE CLERCQ, Leuven, Belgium C. D. PLATSOUCAS, Norfolk, VA, USA Advertising: All correspondence and rate requests should be addressed to the Editorial Office. W. DEN OTTER, Amsterdam , The Netherlands A. POLLIACK, Jerusalem, Israel Book Reviews: Recently published books and journals should be sent to E. P. DIAMANDIS, Toronto, ON, Canada D. RADES , L beck, Germany ü the Editorial Office. Reviews will be published within 2-4 months. G. TH. DIAMANDOPOULOS, Boston, MA, USA M. RIGAUD, Limoges, France Articles in ANTICANCER RESEARCH are regularly indexed in all L. EGEVAD , Stockholm, Sweden U. RINGBORG, Stockholm, Sweden bibliographic services, including Current Contents (Life Sciences), Science D. W. FELSHER , Stanford, CA, USA M. ROSELLI, Rome, Italy Citation Index, Index Medicus, Biological Abstracts, PubMed, Chemical J. A. FERNANDEZ-POL, Chesterfield, MO, USA S.T. ROSEN, Duarte, CA, USA Abstracts, Biosis Previews , Essential Science Indicators , Excerpta Medica, I. J. FIDLER, Houston, TX, USA A. SCHAUER, G ttingen, Germany ö University of Sheffield Biomedical Information Service, Current Clinical A. P. FIELDS, Jacksonville, FL, USA M. SCHNEIDER, Wuppertal, Germany Cancer, AIDS Abstracts, Elsevier Bibliographic Database, EMBASE, H. FU, Atlanta, GA, USA J. SEHOULI, Berlin, Germany Compendex, GEOBASE, EMBiology, Elsevier BIOBASE, FLUIDEX, World B. FUCHS, Zurich, Switzerland A. SETH, Toronto, ON, Canada Textiles, Scopus, Progress in Palliative Care, Cambridge Scientific Abstracts, D. FUCHS, Innsbruck, Austria G. V. SHERBET, Newcastle-upon-Tyne, UK Cancergram (International Cancer Research Data Bank), MEDLINE, Reference Update - RIS Inc., PASCAL-CNRS, Inpharma-Reactions (Datastar, D. FUKUMURA, Boston, MA, USA A. SLOMINSKI, Birmingham, AL, USA BRS), CABS, Immunology Abstracts, Telegen Abstracts, Genetics Abstracts, G. GABBIANI, Geneva, Switzerland G.-I. SOMA, Kagawa, Japan Nutrition Research Newsletter, Dairy Science Abstracts, Current Titles in R. GANAPATHI, Charlotte, NC, USA G. S. STEIN, Burlington, VT, USA Dentistry, Inpharma Weekly, BioBase, MedBase, CAB Abstracts/Global A. F. GAZDAR, Dallas, TX, USA T. STIGBRAND, Ume °a, Sweden Health Databases, Investigational Drugs Database, VINITI Abstracts Journal, A. GIORDANO, Philadelphia, PA, USA T. M. THEOPHANIDES, Athens, Greece Leeds Medical Information, PubsHub, Sociedad Iberoamericana de G. GITSCH, Freiburg, Germany P. M. UELAND, Bergen, Norway Informaci n Cient f ca (SIIC) Data Bases. ó í í M. GNANT, Vienna, Austria H. VAN VLIERBERGHE, Ghent, Belgium Obtaining permission to reuse or reproduce our content: AR has partnered R. H. GOLDFARB, Guilford , CT , USA R. G. VILE, Rochester, MN, USA with Copyright Clearance Center (CCC) to make it easy to secure A. HELLAND, Oslo, Norway M. WELLER, Zurich, Switzerland permissions to reuse its content. Please visit www.copyright.com and enter L. HELSON, Quakertown, PA, USA J. WESTERMARCK, Turku, Finland the title that you are requesting permission for in the ‘Get Permission’ search box. For assistance in placing a permission request, Copyright R. HENRIKSSON, Ume , Sweden B. WESTERMARK, Uppsala, Sweden å Clearance Center can be contacted directly at: Copyright Clearance Center, R. M. HOFFMAN, San Diego, CA, USA Y. YEN, Taipei, Taiwan, ROC 222 Rosewood Drive, Danvers, MA 01923 USA. Phone: +1-978-750- S. C. JHANWAR, New York, NY, USA M.R.I. YOUNG, Charleston, SC, USA 8400. Fax: +1-978-646-8600. E-mail: [email protected]. J. V. JOHANNESSEN, Oslo, Norway B. ZUMOFF, New York, NY, USA The Editors and Publishers of ANTICANCER RESEARCH accept no R. JONES, London, UK G. J. DELINASIOS, Athens, Greece responsibility for the opinions expressed by the contributors or for the B. KAINA, Mainz, Germany content of advertisements appearing therein. Managing Editor and P. -L. KELLOKUMPU-LEHTINEN, Tampere, Executive Publisher Finland Copyright© 2020, Ιnternational Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. D. G. KIEBACK , Schleswig, Germany J. G. DELINASIOS, Athens, Greece
Load more

Recommended publications
  • Journal of Biotechnology
    JOURNAL OF BIOTECHNOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 0168-1656 DESCRIPTION . Journal of Biotechnology provides a medium for the rapid publication of both full-length articles and short communications on novel and innovative aspects of biotechnology. The Journal will accept papers ranging from genetic or molecular biological positions to those covering biochemical, chemical or bioprocess engineering aspects as well as computer application of new software concepts, provided that in each case the material is directly relevant to biotechnological systems. Papers presenting information of a multidisciplinary nature that would not be suitable for publication in a journal devoted to a single discipline, are particularly welcome. The following areas are covered in the Journal: * Nucleic Acids/Molecular Biology * Physiology/Biochemistry * Biochemical Engineering/Bioprocess Engineering * Industrial Processes/New Products * Medical Biotechnology * Agro- and Food Biotechnology * Genomics and Bioinformatics More information on these areas can be foundhere Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center AUDIENCE . Microbiologists, Molecular Biologists, Environmental Scientists, Genetic Engineers. IMPACT FACTOR . 2020: 3.307 © Clarivate Analytics Journal Citation Reports 2021 AUTHOR INFORMATION PACK 28 Sep 2021 www.elsevier.com/locate/jbiotec 1 ABSTRACTING AND INDEXING .
    [Show full text]
  • Curriculum Vitae
    Curriculum Vitae Name and Address: Mohammad Nabiuni (22.04.1967) ID number: 0381613208 No. 43, Mofatteh Ave, Kharazmi University, Department of Cell and Molecular Biology, Faculty of Biological Sciences, Tehran, Iran, Post Cod: 15614, Email Address: [email protected] [email protected] Last Degrees: Post Doc in Neuroscience, University of Central Florida, Orlando, Florida (2007). Ph.D. in Cell and Developmental Biology (Developmental Neuroscience), Manchester, UK, (2006). MSc in Developmental Biology, Tarbiat Moallem University, Tehran, Iran, (1992) BSc in Biology, Urmieh University, Urmieh, Iran, (1989). Current Position: Associate Professor in Cell and Developmental Biology, Department of Cell and Molecular Biology, Kharazmi University, Tehran, Iran. Postgraduate Representative of Cell and Molecular Biology Department in Karaj Campus, Kharazmi University. Technical Experiences: Cell and tissue culture. Proteomoics skills including: Protein identification methods, Mass spectrometry and Electrophoresis (1D &2D), LC/MS methods in proteomics study. Histochemical and Immunocytochemical techniques. Handling and working with laboratory animals (Rodents). Taxidermal skills working with animals for museum and experimental laboratories. Working as co-investigator of project of Iranian Fauna (National project to investigate fauna of Iran) Caspian Sea and Persian Gulf. Teaching Experiences: Four years’ experience in teaching to the PhD, MSc and BSc students in field of Developmental Genetics, Cell and Tissue Culture course, Species and speciation, Evolutionary Biology, Biostatistics and Animal Biodiversity (2007- 2011). Three years experiences as demonstrator at UMIST in Manchester for undergraduate students in field of Histology, Embryology, Cell Biology and Developmental Biology (2002-2005). Eight years’ experience as an instructor of applied biology, experimental embryology, general biology and evolution (Department of Biology, University of Teacher Training, Tehran, Iran, 1992- 2000).
    [Show full text]
  • Journal of Structural Biology
    This Number Completes Volume 191 ISSN 1047-8477 Volume 191, Number 3, September 2015 Journal of Structural Biology CoverFinal.indd 1 8/17/15 12:22 PM JOURNAL OF STRUCTURAL BIOLOGY Editors-in-Chief Alasdair C. Steven Wolfgang Baumeister Silver Spring, Maryland, USA Max-Planck-Institut fu¨r Biochemie D-82152 Martinsried bei Mu¨nchen, Germany Associate Editors Bridget Carragher Bauke W. Dijkstra Andrei Lupas The Scripps Research Institute Groningen University, Max-Planck-Institut fuer La Jolla, California Groningen, The Netherlands Entwicklungsbiologie Tuebingen, Germany Daniel J. Mu¨ ller Rajan Sankaranarayanan Stephen Weiner Eidgenossische Technische Hochschule Centre for Cellular and Molecular Biology Weizmann Institute of Science Basel, Switzerland Hyderabad, India Rehovot, Israel Editorial Board Ueli Aebi Nick Grishin Michael Radermacher Maurice E. Mu¨ ller Institute Southwestern Medical Center University of Vermont Basel, Switzerland Dallas, Texas Burlington, Vermont Linda Amos Dorit Hanein Zihe Rao MRC Laboratory of Molecular Biology The Burnham Institute Tsinghua University Cambridge, United Kingdom La Jolla, California Beijing, China Albert J.R. Heck Tim Baker Ivan Raska University of California Utrecht University Utrecht, The Netherlands Academy of Sciences of the Czech Republic San Diego, California Prague, Czech Republic Harald Herrmann Adriaan Bax German Cancer Research Center Felix Rey National Institute of Diabetes and Heidelberg, Germany Institut Pasteur Digestive and Kidney Diseases (NIDDK) Paris, France Bethesda, Maryland
    [Show full text]
  • MICROBIOLOGY, Faculty of Medicine, Institute of Medical Sciences A
    FORMAT FOR SUBJECTWISE IDENTIFYING JOURNALS BY THE UNIVERSITIES AND APPROVAL OF THE UGC {Under Clause 6.05 (1) of the University Grants Commission (Minimum Qualifications for appointment of Teacher and Other Academic Staff in Universities and Colleges and Measures for the Maintenance of Standards in Higher Education (4th Amendment), Regulations, 2016} Subject: MICROBIOLOGY, Faculty of Medicine, Institute of Medical Sciences A. Refereed Journals Sl. Name of the Journal Publisher and Year of Hard e-publication ISSN Number Peer / Indexing status. Impact Do you use Any other No. place of Start copies (Yes/No) Refree If indexed, Factor/Rating. any Information publication published Reviewed Name of the Name of the IF exclusion (Yes/No) (Yes/No) indexing data assigning agency. criteria for base Whether covered Research by Thompson & Journals Reuter (Yes/No) 1 2 3 4 5 6 7 8 9 10 11 1 J MOL MICROB BIOTECH, Journal of Basel ; New York : Karger, 1999 Yes e-ISSN: 1660- 1464-1801 Yes Index medicus: 1.701 /Thomson molecular microbiology and biotechnology Switzerland 2412 v1n1,Aug. 1999-; Reuter- Y MEDLINE: v1n1; Aug. 1999-PubMed: v1n1,Aug. 1999- 2 LETT APPL MICROBIOL, Letters in applied Oxford, UK : Published for 1985 Yes Online ISSN: 0266-8254 Yes Index medicus: 1.579/ N microbiology the Society for Applied 1472-765X v26n4,Apr. 1998-; Bacteriology by Blackwell MEDLINE: v26n4,Apr. Scientific Publications, 1998-; PubMed: England v26n4,Apr. 1998- 3 MED MICROBIOL IMMUN, Medical Berlin, New York, 1971 Yes 1432-1831 0300-8584 Yes Index medicus: v157n1, 2.302/ N microbiology and immunology Springer-Verlag, (Electronic) 1971-; MEDLINE: GERMANY v157n1, 1971-; PubMed: v157n1, 1971- 4 METHOD MICROBIOL, Methods in Troy Mo : Academic 1969 Yes 0580-9517 Yes microbiology Press, UNITED STATES 5 MICROB DRUG RESIST, Microbial drug Larchmont, N.Y.
    [Show full text]
  • Journal of Molecular Biology
    JOURNAL OF MOLECULAR BIOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.6 ISSN: 0022-2836 DESCRIPTION . Journal of Molecular Biology (JMB) provides high quality, comprehensive and broad coverage in all areas of molecular biology. The journal publishes original scientific research papers that provide mechanistic and functional insights and report a significant advance to the field. The journal encourages the submission of multidisciplinary studies that use complementary experimental and computational approaches to address challenging biological questions. Research areas include but are not limited to: Biomolecular interactions, signaling networks, systems biology Cell cycle, cell growth, cell differentiation Cell death, autophagy Cell signaling and regulation Chemical biology Computational biology, in combination with experimental studies DNA replication, repair, and recombination Development, regenerative biology, mechanistic and functional studies of stem cells Epigenetics, chromatin structure and function Gene expression Receptors, channels, and transporters Membrane processes Cell surface proteins and cell adhesion Methodological advances, both experimental and theoretical, including databases Microbiology, virology, and interactions with the host or environment Microbiota mechanistic and functional studies Nuclear organization Post-translational modifications, proteomics Processing and function of biologically
    [Show full text]
  • Front Matter
    ANTICANCER RESEARCH International Journal of Cancer Research and Treatment ISSN: 0250-7005 Volume 29, Number 1, January 2009 Experimental Studies Contents Bortezomib Therapeutic Effect is Associated with Expression of FGFR3 in Multiple Myeloma Cells. M. GUAN, L. ZHU, G. SOMLO, A. HUGHES, B. ZHOU, Y. YEN (Duarte, CA, USA; Zhejiang, China)........... 1 Utilization of a Right-handed Coiled-coil Protein from Archaebacterium Staphylothermus marinus as a Carrier for Cisplatin. M. ERIKSSON, S. HASSAN, R. LARSSON, S. LINDER, T. RAMQVIST, H. LÖVBORG, T. VIKINGE, E. FIGGEMEIER, J. MÜLLER, J. STETEFELD, T. DALIANIS, S. ÖZBEK (Stockholm; Uppsala; Linköping, Sweden; Basel, Switzerland; Winnipeg, Manitoba, Canada; Heidelberg, Germany)............................. 11 Gene Amplification of Myc and its Coamplification with ERBB2 and EGFR in Gallbladder Adenocarcinoma. A. OOI, S. SUZUKI, K. NAKAZAWA, J. ITAKURA, I. IMOTO, H. NAKAMURA, Y. DOBASHI (Ιshikawa; Yamanishi; Tokyo; Saitama, Japan) ........................................................................................................................ 19 Effect of Verapamil on the Expression of EGFR and NM23 in A549 Human Lung Cancer Cells. C. ZHANG, F. LV, L. ZHOU, X. LI, X.-X. WU, R.M. HOFFMAN (Harbin; Qiqihaer, China; Kagawa, Japan; San Diego, CA, USA) ................................................................................................................................................................. 27 Antioxidant Effects of Quercetin and Coenzyme Q10 in Mini Organ Cultures of Human Nasal Mucosa Cells. M. REITER, K. RUPP, P. BAUMEISTER, S. ZIEGER, U. HARRÉUS (Munich, Germany) ........................... 33 Distinct Patient Responses to Activation of T-cells by Free HER-2, G89 (777-789) and Protected LRMK-linked HER-2, {AE-39 [p776 (Ava-774-788)], AE-47 [(Ava-776-788)] and AE-37[p776 (774-788)]} Peptides Could Lead to Development of Personalized Cancer Vaccines. Y. LI, S. MATSUEDA, C.L.
    [Show full text]
  • Ed Board (PDF)
    CANCER GENOMICS & PROTEOMICS 13 : (2016) Editorial Board A. Seth Editor-in- Chief Laboratory of Molecular Pathology, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada J.G. Delinasios Managing Editor and Executive Publisher International Institute of Anticancer Research, Athens, Greece L.A. Aaltonen Department of Medical Genetics, University of Helsinki, Finland R. Abagyan The Scripps Research Institute, La Jolla, CA, USA F. Ahmed Department of Radiation Oncology, East Carolina University School of Medicine, Greenville, NC, USA D.-T. Bau Terry Fox Cancer Research Lab, China Medical University Hospital, Taichung, Taiwan, ROC R. Clarke Vincent T. Lombardi Cancer Center, Georgetown Univ ersity School of Medicine, Washington, DC, USA T. Efferth Department of Pharmaceutical Biology Institute of Pharmacy and Biochemistry, University of Mainz, Germany N.A. Ellis Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, AZ , USA J.A. Fernandes-Pol Metalloproteomics, LLC, Chesterfield , MO, USA C.V. Forst Department of Genetics and Genomic Sciences, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA D.S. Gerhard NIH / NCI, Office of Cancer Genomics, Bethesda, MD, USA T.R. Golub Pediatric Oncology, Dana-Farber Cancer Institute, Cambridge, MA, USA J. Gordon Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA C.-H. Heldin Ludwig Institute for Cancer Research, Uppsala, Sweden J.D. Hoheisel Deutsches Krebsforschungszentrum, Genome Research and Bioinformatics, Heidelberg, Germany T.H.M. Huang Department of Molecular Medicine/Institute of Biotechnology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA S.C.
    [Show full text]
  • TOXICOLOGY Affiliated with the German Toxicology Society
    TOXICOLOGY Affiliated with the German Toxicology Society AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 0300-483X DESCRIPTION . Toxicology as a multidisciplinary, data-rich field has witnessed the availability of a cutting-edge technologies to investigate mechanisms underlying adverse consequences of exposures to xenobiotic chemicals, particularly as it relates to human health. Toxicology fully embraces these advancements by serving as a hub for exchange of information regarding state-of-the-art developments in the broad field of contemporary toxicology. Journal scope emphasis is on human-relevant and mechanistic research at all levels of biological organization, ranging from the molecular scale to the organismal level. The publication priority for Toxicology is on original high-quality research and review papers on any topic relevant to toxicology, in particular related to hazard identification, all that are subject to rigorous peer-review. The Toxicology target audience includes undergraduates to full professionals in academic, industrial and regulatory settings in any part of the world. Notes from the Editors In order to support interpretation of published findings to human health, the journal requires inclusion of specific statements within the ABSTRACT and METHODS sections of each submitted article: ABSTRACT: The experimental system (e.g., in vivo species, cell culture, etc.) including the exposure dose or concentration and duration that produces an effect, if an effect is observed, must be described in the ABSTRACT to the manuscript.MATERIALS AND METHODS: The relevance of the experimental system and exposure dose or concentration and duration in terms of potential human exposures must be described in the Materials and Methods section of the manuscript.
    [Show full text]
  • Ed Board (PDF)
    CANCER GENOMICS & PROTEOMICS 8: (2011) Editorial Board A. Seth Editor-in- Chief Laboratory of Molecular Pathology, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada J.G. Delinassios Managing Editor and Executive Publisher, International Institute of Anticancer Research, Athens, Greece L.A. Aaltonen Department of Medical Genetics, University of Helsinki, Finland R. Abagyan The Scripps Research Institute, La Jolla, CA, USA F. Ahmed Department of Radiation Oncology, East Carolina University School of Medicine, Greenville, NC, USA S. Antonarakis Division of Medical Genetics, University of Geneva Medical School, Switzerland D.-T. Bau Terry Fox Cancer Research Lab, China Medical University Hospital, Taichung, Taiwan A.M. Burger Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA M.R. Chance Case Western Reserve University, Center for Proteomics and Bioinformatics, Cleveland, OH, USA A.M. Chinnaiyan Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA B.F.C. Clark Department of Molecular Biology, University of Aarhus, Denmark R. Clarke Vincent T. Lombardi Cancer Center, Georgetown Univ ersity School of Medicine, Washington, DC, USA N. E. Davidson University of Pittsburgh, Cancer Institute, Pittsburgh, PA, USA I. Dunham European Bioinformatics Institute , Wellcome Trust Genome Campus, Cambridge, UK T. Efferth Department of Pharmaceutical Biology Institute of Pharmacy and Biochemistry, University of Mainz, Germany J.A. Fernandes-Pol Metalloproteomics, LLC, Chesterfield , MO, USA C.V. Forst Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, USA M. Fountoulakis F. Hoffman-La Roche Pharmaceutical Research, Basel, Switzerland D.S. Gerhard NIH / NCI, Office of Cancer Genomics, Bethesda, MD, USA J.W.
    [Show full text]
  • Vol. 78 2019 No. 2
    ISSN 0015–5659 Impact Factor: 0.497 Folia Morphol. Vol. 78, No. 2, May 2019 2018 Vol. 77 No. 2, pp. 171–408 2019, Vol. 78, No. 2, pp. 221–454 CONTENTS ORIGINAL ARTICLES Evaluation of PECAM-1 and p38 MAPK expressions in cerebellum tissue of rats treated with caffeic acid phenethyl ester: a biochemical and immunohistochemical study.........................221 A. Çetin, E. Deveci The effect of prolonged formalin fixation on the staining characteristics of archival human brain tissue ............................................................................................................................230 A. Alrafiah, R. Alshali Aging changes in the retina of male albino rat: a histological, ultrastructural and immunohistochemical study .......................................................................................................237 M.E.I. Mohamed, E.A.A. El-Shaarawy, M.F. Youakim, D.M.A. Shuaib, M.M. Ahmed Anatomical variations and dimensions of arteries in the anterior part of the circle of Willis ..........259 J. Shatri, S. Cerkezi, V. Ademi, V. Reci, S. Bexheti Morphological study of myelinated and unmyelinated fibres in the sacrococcygeal dorsal roots of the rat ........................................................................................................................267 J.-C. Lee, C.-H. Cheng, C.-T. Yen Combination of vitamin E and L-carnitine is superior in protection against isoproterenol-induced cardiac injury: histopathological evidence ....................................................274 E.A. Huwait
    [Show full text]
  • Food Microbiology
    FOOD MICROBIOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.5 ISSN: 0740-0020 DESCRIPTION . Food Microbiology publishes original research articles, short research communications, and review papers dealing with all aspects of the microbiology of foods. The editors aim to publish manuscripts of the highest quality which are both relevant and applicable to the broad field covered by the journal. Studies must be novel and have a clear connection to the microbiology of foods or food production environments. The microbiological aspects of all stages of food production, from pre- to post-harvest and throughout processing and preparation, are of interest. Studies should be of general interest to the international community of food microbiologists. The editors make every effort to ensure rapid and fair reviews, resulting in timely publication of accepted manuscripts. Papers relating to the following topics will be considered: • Taxonomy, Physiology, genetics, biochemistry, and behavior of microorganisms that are either used to make foods or that represent safety or quality problems • Effects of preservatives, including bioprotectants, processes, and packaging systems on the microbiology of foods • Methods for detection, identification and enumeration of foodborne microorganisms or microbial toxins • Microbiology of food fermentations • Predictive microbiology and applications to foods • Microbial communities and ecology of foods,
    [Show full text]
  • Ed Board (PDF)
    CANCER GENOMICS & PROTEOMICS 13 : (2016) Editorial Board A. Seth Editor-in- Chief Laboratory of Molecular Pathology, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada J.G. Delinasios Managing Editor and Executive Publisher International Institute of Anticancer Research, Athens, Greece L.A. Aaltonen Department of Medical Genetics, University of Helsinki, Finland R. Abagyan The Scripps Research Institute, La Jolla, CA, USA F. Ahmed Department of Radiation Oncology, East Carolina University School of Medicine, Greenville, NC, USA D.-T. Bau Terry Fox Cancer Research Lab, China Medical University Hospital, Taichung, Taiwan, ROC R. Clarke Vincent T. Lombardi Cancer Center, Georgetown Univ ersity School of Medicine, Washington, DC, USA T. Efferth Department of Pharmaceutical Biology Institute of Pharmacy and Biochemistry, University of Mainz, Germany N.A. Ellis Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, AZ , USA J.A. Fernandes-Pol Metalloproteomics, LLC, Chesterfield , MO, USA C.V. Forst Department of Genetics and Genomic Sciences, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA D.S. Gerhard NIH / NCI, Office of Cancer Genomics, Bethesda, MD, USA T.R. Golub Pediatric Oncology, Dana-Farber Cancer Institute, Cambridge, MA, USA J. Gordon Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA C.-H. Heldin Ludwig Institute for Cancer Research, Uppsala, Sweden J.D. Hoheisel Deutsches Krebsforschungszentrum, Genome Research and Bioinformatics, Heidelberg, Germany T.H.M. Huang Department of Molecular Medicine/Institute of Biotechnology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA S.C.
    [Show full text]